Exponent, Inc. (EXPO)

NASDAQ: EXPO · IEX Real-Time Price · USD
102.31
+3.21 (3.24%)
Aug 12, 2022 4:00 PM EDT - Market closed
3.24%
Market Cap 5.23B
Revenue (ttm) 478.27M
Net Income (ttm) 99.96M
Shares Out 51.12M
EPS (ttm) 1.89
PE Ratio 54.13
Forward PE 51.02
Dividend $0.88 (0.86%)
Ex-Dividend Date Sep 8, 2022
Volume 240,927
Open 99.10
Previous Close 99.10
Day's Range 97.82 - 102.41
52-Week Range 80.97 - 127.61
Beta 0.57
Analysts Buy
Price Target 122.40 (+19.6%)
Earnings Date Jul 28, 2022

About EXPO

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polym... [Read more...]

Industry Professional Services
IPO Date Aug 17, 1990
CEO Catherine Corrigan
Employees 1,215
Stock Exchange NASDAQ
Ticker Symbol EXPO
Full Company Profile

Financial Performance

In 2021, Exponent's revenue was $466.27 million, an increase of 16.60% compared to the previous year's $399.90 million. Earnings were $101.20 million, an increase of 22.59%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for EXPO stock is "Buy." The 12-month stock price forecast is 122.4, which is an increase of 19.64% from the latest price.

Price Target
$122.4
(19.64% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Exponent (EXPO) Q2 Earnings Surpass Estimates

Exponent (EXPO) delivered earnings and revenue surprises of 8.89% and 0.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Exponent Reports Second Quarter 2022 Financial Results

MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2022 ended July 1, 2022.

Exponent Declares Regular Quarterly Dividend

MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock t...

Exponent to Announce Second Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on July 28, 2022

MENLO PARK, Calif., July 07, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report second quarter of fiscal year 2022 financial results for the period ended July 1, ...

Exponent to Present at Upcoming Investor Conferences

MENLO PARK, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vic...

After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for Exponent (EXPO)

The heavy selling pressure might have exhausted for Exponent (EXPO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in ...

Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 19.9% in 4 Weeks

Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ea...

Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 16.5% in 4 Weeks

Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ea...

Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 14.6% in 4 Weeks

Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ea...

Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates

Exponent (EXPO) delivered earnings and revenue surprises of 7.69% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Exponent Reports First Quarter 2022 Financial Results

MENLO PARK, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2022 ended April 1, 2022.

Exponent Trading In New Buy Range With Earnings On Tap

To build your earnings season watch list, look for stocks in or near a potential buy zone ahead of their next report. Exponent currently fits that bill.

Exponent to Announce First Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on April 28, 2022

MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report first quarter of fiscal year 2022 financial results for the period ended April 1,...

New Strong Sell Stocks for March 4th

AMED, CACC, and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2022

Other symbols: AMEDCACC

Exponent Increases Share Repurchase Authorization by $150 Million

MENLO PARK, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors approved a $150 million expansion of its share repurchase program, adding t...

Exponent (EXPO) Q4 Earnings and Revenues Beat Estimates

Exponent (EXPO) delivered earnings and revenue surprises of 5.56% and 2.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Exponent Reports Fourth Quarter and Fiscal Year 2021 Financial Results

MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021.

Exponent Increases Quarterly Dividend Payment from $0.20 to $0.24 per Share

MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has raised its quarterly dividend by 20% from $0.20 to $0.24 per share of c...

Analysts Estimate Exponent (EXPO) to Report a Decline in Earnings: What to Look Out for

Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Exponent to Announce Fourth Quarter and Fiscal Year 2021 Results and Host Quarterly Conference Call on February 3, 2022

MENLO PARK, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report fourth quarter and fiscal year 2021 financial results for the period ended Decembe...

Exponent Inc. Recognized in Investor Business Daily's List Of 100 Best ESG Companies of 2021

MENLO PARK, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced it was recently recognized in Investor Business Daily's third annual List Of 100 Best ESG Companies of ...

Exponent to Present at Upcoming Investor Conference

MENLO PARK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vi...

Exponent (EXPO) Q3 Earnings and Revenues Surpass Estimates

Exponent (EXPO) delivered earnings and revenue surprises of 15.00% and 3.83%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Exponent Reports Third Quarter of Fiscal Year 2021 Financial Results

MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2021 ended October 1, 2021.

Exponent (EXPO) Reports Next Week: Wall Street Expects Earnings Growth

Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.